Artiva Biotherapeutics
The Analytical Development Scientist will develop and optimize flow cytometry and cell‑based assays to support the characterization and release of allogeneic NK cell therapies. The role involves assay design, qualification, documentation, and transfer to QC, while collaborating with R&D, process development, and quality teams.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2019
Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for autoimmune diseases. Their lead product candidate, AlloNK®, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs) across multiple clinical trials, including basket trials in rheumatoid arthritis and Sjögren's disease. The company leverages highly scaled, off-the-shelf, allogeneic NK cell manufacturing to make cell therapies broadly accessible to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Artiva Biotherapeutics.
6% below the average for this role
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Scientist I, Analytical Development
ImmunityBio
Scientist, Quality Control & Analytical Development
Aspect Biosystems
Senior Scientist I, Analytical Development, Biologics CMC
Exelixis
Scientist II, Analytical Development
Aurion Biotech
Molecular Biology Analytical Scientist
Eurofins